◆ NeutralIBRX
ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
GlobeNewswire Inc.·
Rosen Law Firm is reminding investors who purchased ImmunityBio securities between January 19, 2026 and March 24, 2026 of the May 26, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that defendants made false and misleading statements about Anktiva's capabilities and ImmunityBio's business operations and prospects.
Read Full Article at GlobeNewswire Inc. →